Author:
Nomura M.,Kamata M.,Kojima H.,Hayashi K.,Sawada S.
Reference20 articles.
1. Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection—the results of a multicentre, double-blind, randomized clinical trial (IMPACT study);Hiraishi;Aliment Pharmacol Ther,2010
2. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease: an open-label, single-centre study;Nanke;Drugs R D,2008
3. Therapeutic benefits of irsogladine maleate on aphthous stomatitis induced by methotrexate in rheumatoid arthritis;Yoshida;J Rheumatol,2003
4. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils;Kyoi;Life Sci,2004
5. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis;Kyoi;Life Sci,2004
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献